Long-term potentiation of hypothalamic alpha-MSH release by NMDA.
Wayman
C P
CP
Department of Pharmacology and Therapeutics, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.
Wilson
J F
JF
D000818:Animals; D005475:Flupenthixol / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D016202:N-Methylaspartate / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000494:pharmacology; D013997:Time Factors; D000521:alpha-MSH / Q000378:metabolism*
D012701:Serotonin; D000521:alpha-MSH; D016202:N-Methylaspartate; D005475:Flupenthixol